Cargando…
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and is characterized by poor clinical outcomes, with the majority of patients not being eligible for curative therapy and treatments only being applicable for early-stage tumors. CD44 is a receptor for hyaluronic acid (HA) and...
Autores principales: | Cannito, Stefania, Bincoletto, Valeria, Turato, Cristian, Pontisso, Patrizia, Scupoli, Maria Teresa, Ailuno, Giorgia, Andreana, Ilaria, Stella, Barbara, Arpicco, Silvia, Bocca, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840578/ https://www.ncbi.nlm.nih.gov/pubmed/35164326 http://dx.doi.org/10.3390/molecules27031062 |
Ejemplares similares
-
Nanotechnological approaches for pentamidine delivery
por: Andreana, Ilaria, et al.
Publicado: (2022) -
Freeze Drying of Polymer Nanoparticles and Liposomes Exploiting Different Saccharide-Based Approaches
por: Andreana, Ilaria, et al.
Publicado: (2023) -
Hyaluronic Acid–Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells
por: Pandolfi, Laura, et al.
Publicado: (2019) -
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle
por: Calderan, Laura, et al.
Publicado: (2022) -
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis
por: Pandolfi, Laura, et al.
Publicado: (2021)